An interventional study of Mechanical unloading of the Thorax using an external cuirass in Obesity and Aging, sponsored by University of Texas Southwestern Medical Center. Completed at 1 site in United States. Open to participants aged 65 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 31 studies in Obesity by University of Texas Southwestern Medical Center — 6 open to participants now, 7 under way, none of them phase 3. Obesity · University of Texas Southwestern Medical Center.
Among the 31 studies in Obesity by University of Texas Southwestern Medical Center, this one is the 12th largest by enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2021, is one of 16 with no phase, and was the 21st registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →6 of the 31 studies in Obesity by University of Texas Southwestern Medical Center are open now, in 1 country. Recruiting first, the newest first:
University of Texas Southwestern Medical Center · Sites in United States
Ages 18–65
University of Texas Southwestern Medical Center · Sites in United States
Ages 6–14
University of Texas Southwestern Medical Center · Sites in United States
Ages 18–45 · Women only · Healthy volunteers
University of Texas Southwestern Medical Center · Sites in United States
Ages 55–90 · Healthy volunteers
University of Texas Southwestern Medical Center · Sites in United States
Ages 18–55 · Healthy volunteers
By country, each count listing its studies:
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 65 Years to 75 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 3 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 50 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 48 across the 24 interventional studies, 95 across the 7 observational. Of the 24 that completed or were terminated, 13 (54%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Texas Southwestern Medical Center is the lead sponsor of 1,012 studies on the registry; 200 are open to participants now.
Of its 139 completed or terminated interventional studies of FDA-regulated products, 105 (76%) have results posted.
3 of the studies in Obesity by University of Texas Southwestern Medical Center that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04838678University of Texas Southwestern Medical CenterSympathetic Transduction in Obesity-associated Hypertension (OB-HTN) | 2026-12-31 |
| NCT06924177University of Texas Southwestern Medical CenterUTSW NORC Pilot Spinal Cord Injury Dietary Program | 2027-05-31 |
| NCT07342855University of Texas Southwestern Medical CenterComparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program | 2027-06-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 31 studies in Obesity by University of Texas Southwestern Medical Center, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The overall objective of this application is to investigate the effects of obesity on lung function, exercise tolerance, and DOE in older obese adults as compared with older adults without obesity, using a novel probe for mechanically unloading the thorax at rest and during exercise. The investigators will use 1) continuous negative cuirass pressure, and 2) assisted biphasic cuirass ventilation to decrease obesity-related effects in older obese adults. Our approach will be to examine respiratory function, exercise tolerance, and DOE with and without mechanical unloading in older obese men and women (65-75 yr), including those with respiratory symptoms (defined by a score of 1 or 2 on the modified Medical Research Council Dyspnea Scale), as compared with older adults without obesity.
Specific Aims: The investigators will test the following hypotheses in older adults with and without obesity:
Aim 1) Obesity will decrease respiratory function but to a greater extent in older obese adults with respiratory symptoms, (as evidenced by altered pulmonary function and breathing mechanics at rest); Aim 2) Obesity will decrease exercise tolerance (as evidenced by peak V•O2 in ml/min/kg, i.e., physical fitness), but not cardiorespiratory fitness (as evidenced by peak V•O2 in % of predicted based on ideal body wt), except in older obese adults with respiratory symptoms where both may be reduced during graded cycle ergometry.
Aim 3) Obesity will increase DOE but to a greater extent in older obese adults with respiratory symptoms as evidenced by increased ratings of perceived breathlessness (sensory \& affective dimensions) during exercise.
Aim 4) Mechanical unloading of the thorax will improve respiratory function, submaximal exercise tolerance, and DOE in older obese adults, but to a greater extent in older obese adults with respiratory symptoms.
Over 40% of older adults (60+ yr) are obese and 30% are overweight. While regular exercise is an important component in the prevention and treatment of obesity, many older adults with obesity are unable or unwilling to exercise due to exercise intolerance and/or dyspnea on exertion (DOE). The Investigators have identified numerous obesity-related respiratory effects that could influence exercise tolerance and DOE in younger obese adults including decreased pulmonary function altered respiratory mechanics increased work of breathing and increased metabolic demands of exercise. The Investigators have also identified many age-related ventilatory constraints in older adults without obesity. However, it is unclear whether these obesity-related and aging-related effects combine to reduce exercise tolerance, impose DOE, or contribute to respiratory symptoms in older obese adults. Respiratory symptoms in older adults are often wrongly diagnosed as deconditioning and/or cardiopulmonary disease, placing older obese adults at risk of costly clinical testing, unnecessary treatment, and potentially a reluctance to exercise, which is counterproductive to weight loss (WL) and the preservation of functional capacity, thus further diminishing their quality of life. The respiratory effects of obesity are underappreciated and have not been carefully examined in older adults, especially older obese adults with "respiratory symptoms" who may experience even greater respiratory effects.
The Investigators propose that many of the obesity-related respiratory effects in older obese adults are the result of low lung volume breathing, i.e., a reduction in functional residual capacity (FRC) at rest (seated upright \& supine), and end-expiratory lung volume (EELV) during exercise. The Investigators suggest that increased fat on the chest wall (i.e., abdomen \& rib cage) produces low FRC and EELV levels, where breathing limitations like expiratory flow limitation and enhanced perception of dyspnea are more likely to occur. This is because older adults have an age-related decline in maximal expiratory flow at low lung volumes. As such, excess fat on the thorax appears to exert an unfavorable burden on the older obese adult, particularly during exercise. Our overall hypothesis is that respiratory limitations, exercise intolerance, DOE, and respiratory symptoms in older obese adults are due to mechanical loading of the thorax and low lung volume breathing coupled with the age-related decline in maximal expiratory flow. The Investigators propose to test this hypothesis with the use of an external cuirass (i.e., a plastic shell over the thorax) to mechanically unload the chest wall.
Although our laboratory has used modest WL in younger obese women to reduce the effects of obesity, the mechanisms by which WL (i.e., decreased fat over the entire body) decreases DOE remain unclear. This may be in part due to our single global assessment of DOE (i.e., sensory domain only \& pre-post WL only), and/or that changes in DOE in the time domain are not in parallel with WL. To circumvent these limitations of WL, an external cuirass will be used to mechanically unload the chest wall (includes rib cage \& abdomen) in older obese adults. This will effectively decrease the load on the chest wall thereby increasing FRC at rest and EELV during exercise (i.e., via continuous negative cuirass pressure), and potentially decreasing the work of breathing during exercise (i.e., via assisted biphasic cuirass ventilation). This novel and quantifiable probe will allow us to investigate the effects of obesity in older adults and their influence on lung function, exercise tolerance, and DOE (sensory \& affective dimensions). The proposed mechanistic studies would lead to a better understanding of the mechanical effects of obesity in older adults, which could alter testing and treatment strategies for older obese adults, especially those with exercise intolerance, DOE, and respiratory symptoms.
The overall objective of this application is to investigate the effects of obesity on lung function, exercise tolerance, and DOE in older obese adults as compared with older adults without obesity, using a novel probe for mechanically unloading the thorax at rest and during exercise. The Investigators will use 1) continuous negative cuirass pressure, and 2) assisted biphasic cuirass ventilation to decrease obesity-related effects in older obese adults. Our approach will be to examine respiratory function, exercise tolerance, and DOE with and without mechanical unloading in older obese men and women (65-75 yr), including those with respiratory symptoms (defined by a score of 1 or 2 on the modified Medical Research Council Dyspnea Scale), as compared with older adults without obesity.
Specific Aims: The Investigators will test the following hypotheses in older adults with and without obesity:
Aim 1) Obesity will decrease respiratory function but to a greater extent in older obese adults with respiratory symptoms, (as evidenced by altered pulmonary function and breathing mechanics at rest); Aim 2) Obesity will decrease exercise tolerance (as evidenced by peak V•O2 in ml/min/kg, i.e., physical fitness), but not cardiorespiratory fitness (as evidenced by peak V•O2 in % of predicted based on ideal body wt), except in older obese adults with respiratory symptoms where both may be reduced during graded cycle ergometry.
Aim 3) Obesity will increase DOE but to a greater extent in older obese adults with respiratory symptoms as evidenced by increased ratings of perceived breathlessness (sensory \& affective dimensions) during exercise.
Aim 4) Mechanical unloading of the thorax will improve respiratory function, submaximal exercise tolerance, and DOE in older obese adults, but to a greater extent in older obese adults with respiratory symptoms.
The investigators' long-term objective is to examine the effects of obesity in older obese adults and provide novel results that could clarify the mechanisms of respiratory limitations, exercise intolerance, DOE, and/or obesity-related respiratory symptoms in older obese adults. Thus, these results will have broad and immediate clinical impact on the care of older adults with obesity, especially those with exercise intolerance, DOE, and/or respiratory symptoms.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Older group of adults (65-75 yrs). Everyone enrolled uses the 'intervention'/ external cuirass - mechanical unloading of thorax
Other: Mechanical unloading of the Thorax using an external cuirass
External cuirass (i.e., a plastic shell over the thorax) will be used to mechanically unload the chest wall. The cuirass has different operating modes. It can generate a constant negative pressure over the chest wall (e.g., -20cmH2O) or it can be triggered off mouth flow so it can generate a negative pressure on the chest wall during inspiration (e.g., -21cmH2O) and a positive pressure during expiration (e.g., +7cmH2O).
Change in Pulmonary Function: Lung Volumes
Pulmonary function is comprised of several physiological variables but this study will primarily measure Lung Volume: FRC (liters) and TLC (liters)
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)
Change in Exercise Tolerance - Peak VO2
Exercise Tolerance is represented by several physiological variables but the primary variable is Maximal oxygen uptake (L/min and percent predicted)
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic).
Change in Dyspnea on Exertion
Dyspnea on Exertion is represented using the Borg Scale which provides Ratings of Perceived Breathlessness (RPB) during constant load exercise cycling. The Borg Scale measures from 0-10, where 0 = no breathlessness and 10 = maximal breathlessness.
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic).
Changes in PANAS Questionnaire
Positive and Negative Affect Schedule. This scale consists of a number of words that describe different feelings and emotions.
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic).
Modified Medical Research Council Dyspnea Scale (mMRC Dyspnea Scale)
Investigate the qualities of respiratory sensations (e.g., "effort of breathing", "breathing heavy", "breathing shallow") during exercise before and after mechanical unloading of the chest wall
Time frame: Outcome measures will be assessed immediately after completion of mMRC questionnaire (during study visit 2)
Dyspnoea-12
This questionnaire is designed to help us learn more about how their breathing is troubling them.
Time frame: Outcome measures will be assessed immediately after completion of Dyspnoea-12 questionnaire (during study visit 2)
ASI
The Anxiety Sensitivity Index (ASI) is a 16 item scale containing items specifying different concerns someone could have regarding their anxiety.
Time frame: Outcome measures will be assessed immediately after completion of ASI questionnaire (during study visit 2)
HADS
HADS (Hospital Anxiety and Depression Scale) aims to measure symptoms of anxiety (HADS Anxiety) and depression (HADS Depression). HADS score: 0-7 = normal; 8-10 = mild; 11-14 = moderate; 15-21 = severe
Time frame: Outcome measures will be assessed immediately after completion of HADS questionnaire (during study visit 2)
SDS-MC
The Marlowe-Crowne Social Desirability Scale (MC-SDS) is a 33-item self-report questionnaire that assesses whether or not respondents are concerned with social approval.
Time frame: Outcome measures will be assessed immediately after completion of MC-SDS questionnaire (during study visit 2)
IPAQ
International Physical Activity Questionnaires (IPAQ) is a 27-item self-reported measure of physical activity
Time frame: Outcome measures will be assessed immediately after completion of IPAQ questionnaire (during study visit 2)
WSQ
Workforce Sitting Questionnaire (WSQ) is to estimate how much time they usually spend sitting in each of the following activities on a working day and a non-working day.
Time frame: Outcome measures will be assessed immediately after completion of WSQ questionnaire (during study visit 2)
SF-12
SF-12 is a health-related quality-of-life questionnaire
Time frame: Outcome measures will be assessed immediately after completion of SF-12 questionnaire (during study visit 2)
Changes in forced vital capacity (FVC)
FVC is the total amount of air (liters) exhaled during the forced expiratory volume (FEV) lung function test during spirometry.
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)
Changes in forced expiratory volume (FEV)
FEV is the amount of air (liters) a person can exhale during a forced breath. The amount of air exhaled is measured during the a lung function test during spirometry.
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)
Changes in forced expiratory volume in 1 second (FEV1)
FEV1 is the maximum amount of air (liters) that the a participant can forcibly expel during the first second following maximal inhalation. The FEV1 is measured during the a lung function test during spirometry.
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)
Changes in FEV1/FVC Ratio
The FEV1/FVC (%) ratio is a calculation often used to determine the presence of obstructive or restrictive lung diseases such as chronic obstructive pulmonary disease (COPD).
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)
Changes is peak flow
Peak flow measurement is done with a peak flow meter. It measures the maximum (or peak) speed at which air (liters/sec) can be blown out of the lungs. This measurement provides a general idea of how narrow the lung airways are. It can also show how much the airways are changing over time if measured each day.
Time frame: ChangesOutcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic) between conditions (visits 3-6) compared to baseline between cohorts
Pulmonary Function: Diffusing Capacity
Diffusing Capacity: Diffusing capacity of lung for carbon monoxide(DLco) (ml/mmHg/min)
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)
Exercise Tolerance: Work Rate
Associated variables such as work rate (W)
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)
Exercise Tolerance: Minute Ventilation
Associated variables such as pulmonary ventilation (L/min)
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)
Exercise Tolerance: Operational Lung Volumes
Associated variables such as operational lung volumes (EELV and EILV as a % of TLC)
Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)
Ran from Dec 2021 to primary completion in Jul 2025, 43 months.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 43 months is above that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Dec 2026 → Jul 2025 and completion Dec 2026 → Jul 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Texas Southwestern Medical Center →